Mizuho Securities Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
MKM Partners Downgrades Auxilium Pharmaceuticals (AUXL) to Neutral
October 10, 2014 7:04 AM EDTMKM Partners downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.
For an analyst ratings summary and ratings history on Auxilium Pharmaceuticals click here. For more ratings news on Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $32.44 yesterday.
... MoreEndo Int'l (ENDP) to Acquire Auxilium (AUXL) in $2.6B Deal
October 9, 2014 6:31 AM EDTEndo Int'l (NASDAQ: ENDP) and Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction. The boards of directors of both companies have unanimously approved the transaction, which is valued at $2.6 billion, including the repayment and assumption of debt. The transaction will include an election mechanism for Auxilium stockholders to elect cash and stock, all-stock or all-cash... More
